3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other hematologic neoplasm
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Lung Neoplasms
2
Breast Neoplasms
2
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Sarcoma
1
Prostatic Neoplasms
1
Neoplasms
1
Melanoma
1
Liver Neoplasms
1
Leukemia
1
Kidney Neoplasms
1
Glioblastoma
1
Esophageal Neoplasms
1
Disease
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Bronchogenic
1
Interventions
Colonoscopy
5
Surveys and Questionnaires
3
Methods
2
Liquid Biopsy
2
Interviews as Topic
2
Exercise
2
Capecitabine
2
Biopsy, Fine-Needle
2
Bevacizumab
2
weifuchun
1
tislelizumab
1
pembrolizumab
1
irinotecan sucrosofate
1
fluorocholine
1
bermekimab
1
Water
1
Therapeutics
1
TKM-080301
1
Surgical Procedures, Operative
1
Standard of Care
1
S-Adenosylmethionine
1
Preoperative Exercise
1
Positron Emission Tomography Computed Tomography
1
Nutritional Status
1
Nutrition Assessment
1
Needles
1
MicroRNAs
1
Magnetic Resonance Imaging
1
Interleukin-15
1
High-Intensity Interval Training
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Disease
×
Interleukin-15
×
Gastrointestinal
×
Clear all
NCT07410676
2026-02-18
EBNK-ST-001
Essen Biotech
Phase 1/2
Recruiting
83 enrolled